|
Market Closed -
Nasdaq
16:00:00 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 22.26 USD | +1.09% |
|
-1.37% | - |
| 09-01 | Jefferies Initiates Latigo Biotherapeutics at Buy With $50 Price Target | MT |
| 09-01 | Leerink Partners Initiates Latigo Biotherapeutics at Outperform With $36 Price Target | MT |
Evolution of the Average Target: Latigo Biotherapeutics, Inc.
Evolution of the Target Price: Latigo Biotherapeutics, Inc.
Changes in Analyst Recommendations: Latigo Biotherapeutics, Inc.
301.ojbq19D4SWRKhNDz5f6qAm35W7fNA4AlE6Czcd-E-Fc.50KQlZbILkk68rnHkp3udh2IHNSpQs9vZZbyF_LsugjzToGx4qohLX7Ruw~2507ba2a826b2fcc9b802ab17524addd
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +18.13% | |||||
| +21.02% | |||||
| +5.35% | |||||
| +20.18% | |||||
| +40.83% | |||||
| -2.05% | |||||
| +19.48% | |||||
| -0.02% | |||||
| -2.51% | |||||
| Average | +13.38% | |||||
| Weighted average by Cap. | +16.49% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
22.26USD
Average target price
61.50USD
Spread / Average Target
+176.28%
High Price Target
73.00USD
Spread / Highest target
+227.94%
Low Price Target
50.00USD
Spread / Lowest Target
+124.62%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- LTGO Stock
- Consensus Latigo Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
